UCLA researchers have identified a promising strategy to make a new class of targeted cancer therapies more effective against one of the deadliest forms of prostate cancer, potentially overcoming treatment resistance that ...
Aug 4, 2026
0
9
Cancer develops when the body's systems for controlling cell growth break down, allowing cells to multiply unchecked. Texas A&M researchers have identified two naturally occurring molecules that appear to help restore those ...
Jul 16, 2026
0
9
In a phase 1 clinical trial, treatment with the investigational bispecific antibody cevostamab reduced cancer in more than 40% of patients with multiple myeloma, many of whom had already undergone multiple other cancer treatments, ...
Jul 22, 2026
0
9
Imagine if, before starting cancer care, doctors could rapidly identify the most effective chemotherapy, immunotherapy or combination to personalize treatment for a loved one's hard-to-treat pancreatic cancer and improve ...
Aug 21, 2026
0
9
Transgender and gender-diverse (TGD) individuals experience significant health care disparities across the oncology spectrum of care. Systemic barriers, past harmful health care experiences, the sociopolitical climate and ...
Jul 30, 2026
0
9
Triple-negative breast cancer (TNBC) has a frustrating ability to adapt. Although this aggressive form of breast cancer can initially respond well to chemotherapy, cancer cells often find ways to survive, allowing the disease ...
Aug 31, 2026
0
9
New research from UTHealth Houston found firefighters experience measurable biological changes in their blood and urine within 24 hours of fighting a fire—changes that may help identify early cancer risk, the leading cause ...
Aug 24, 2026
0
9
A new study reveals that the cardioprotective drug dexrazoxane significantly reduces heart damage caused by chemotherapy in pediatric cancer patients 15 years or more after treatment ends.
Aug 7, 2026
0
9
A new Houston Methodist-led study published in Clinical Cancer Research reports a breakthrough in understanding why some patients with metastatic breast cancer fail to respond to a common and important early-stage treatment.
Aug 4, 2026
0
9
Scientists at The Wistar Institute have identified a new mechanism behind the chemotherapy resistance that makes ovarian cancer so lethal. In a new study published in The Journal for ImmunoTherapy of Cancer, the researchers ...
Jul 23, 2026
0
9
